Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-19 Sale | 2021-11-19 10:20 am | Flexion Therapeutics Inc | FLXN | Stejbach Mark Director | 12,631 | $8.5 | $107,364 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:19 am | Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director | 27,450 | $8.5 | $233,325 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:17 am | Flexion Therapeutics Inc | FLXN | MERRIFIELD C ANN Director | 19,000 | $8.5 | $161,500 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:16 am | Flexion Therapeutics Inc | FLXN | Lukatch Heath Director | 9,000 | $8.5 | $76,500 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:14 am | Flexion Therapeutics Inc | FLXN | Kwo Elizabeth Director | 4,500 | $8.5 | $38,250 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:12 am | Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director | 1,496,564 | $8.5 | $12,720,794 | 0 (Indirect Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:10 am | Flexion Therapeutics Inc | FLXN | Canute Scott A Director | 9,000 | $8.5 | $76,500 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:09 am | Flexion Therapeutics Inc | FLXN | MAHAFFY PATRICK J Director | 39,824 | $8.5 | $338,504 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:08 am | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel | 133,486 | $8.5 | $1,134,631 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:06 am | Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer | 103,666 | $8.5 | $881,161 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:04 am | Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer | 146,843 | $8.5 | $1,248,166 | 0 (Indirect Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:03 am | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 103,956 | $8.5 | $883,626 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:01 am | Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer | 141,241 | $8.5 | $1,200,549 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 10:00 am | Flexion Therapeutics Inc | FLXN | DRISCOLL FREDERICK W Chief Financial Officer | 30,680 | $8.5 | $260,780 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 09:58 am | Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer | 34,250 | $8.5 | $291,125 | 0 (Direct) | View |
| 2021-11-19 Sale | 2021-11-19 09:56 am | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,122,550 | $8.5 | $9,541,675 | 0 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-19 Equity Swap | 2021-11-23 7:00 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Newtyn Management LLC 10% Owner | 5,900,000 | $0 | 0 (Indirect) | View |
Ownership | 2021-11-23 6:57 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Newtyn Management LLC 10% Owner | 0 | $0 | 5,900,000 (Indirect) | View |